3 completed, 1 active not recruiting, 1 recruiting. 4 Phase 2, 1 Phase 1, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 4 | Completed 3, Recruiting 1 |
| Phase 1 | 1 | Recruiting 1 |
| Phase 4 | 1 | Active not recruiting 1 |
Follow Neurocytoma: new trials by email Literature Review of Neurocytoma trials Research Report on Neurocytoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SJ901: Evaluation of Mirdametinib in Children, Adolescents, and Young Adults With Low-Grade Glioma Mirdametinib - Low-Grade Glioma, Recurrent Low-Grade Glioma | Phase 1 / Phase 2 | Recruiting | St. Jude Children's Research Hospital | 132 | 2021-06-21 | 2026-09-11 |
| Pediatric Long-Term Follow-up and Rollover Study dabrafenib, trametinib - Diffuse Astrocytoma, Anaplastic Astrocytoma | Phase 4 | Active not recruiting | Novartis Pharmaceuticals | 163 | 2019-11-04 | 2026-08-27 |
| Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors Dabrafenib, trametinib, Carboplatin - Diffuse Astrocytoma, Anaplastic Astrocytoma | Phase 2 | Completed | Novartis Pharmaceuticals | 151 | 2017-12-28 | 2023-12-13 |
| Antineoplaston Therapy in Treating Children With Brain Tumors Antineoplaston therapy (Atengenal + Astugenal) - Childhood Brain Tumors | Phase 2 | Completed | Burzynski Research Institute | 34 | 1996-09-01 | 2022-03-07 |
| Antineoplaston Therapy in Treating Patients With Brain Tumors Antineoplaston therapy (Atengenal + Astugenal) - Refractory Brain Tumors | Phase 2 | Completed | Burzynski Research Institute | 40 | 1996-07-01 | 2017-08-22 |
Astrocytoma (5) · Ganglioglioma (4) · Glioblastoma (4) · Oligodendroglioma (4) · Ganglioneuroma (3) · Glioma (3) · Neuroectodermal Tumors, Primitive (2) · Brain Neoplasms (1) · Craniopharyngioma (1) · Gliosarcoma (1) · Histiocytosis, Langerhans-Cell (1) · Neoplasms, Neuroepithelial (1) · Neuroblastoma (1) · Neurofibroma, Plexiform (1)
Brain Diseases (5) · Central Nervous System Diseases (5) · Central Nervous System Neoplasms (5) · Neoplasms (5) · Neoplasms by Histologic Type (5) · Neoplasms by Site (5) · Neoplasms, Germ Cell and Embryonal (5) · Neoplasms, Glandular and Epithelial (5) · Neoplasms, Nerve Tissue (5) · Nervous System Diseases (5) · Nervous System Neoplasms (5) · Neuroectodermal Tumors (5) · Brain Neoplasms (4) · Neoplasms, Neuroepithelial (4) · Glioma (2)
antineoplaston A10 (2) · antineoplaston AS 2-1 (2) · dabrafenib (2) · trametinib (2) · Carboplatin (1) · Vincristine (1) · mirdametinib (1)
Burzynski Research Institute (2) · Novartis Pharmaceuticals (2) · St. Jude Children's Research Hospital (1)
United States (5) · Argentina (2) · Australia (2) · Belgium (2) · Brazil (2) · Canada (2) · Czechia (2) · Denmark (2) · Finland (2) · France (2) · Germany (2) · Israel (2) · Italy (2) · Japan (2) · Netherlands (2)
Stanislaw R. Burzynski, MD, PhD (2) · Anna Vinitsky, MD, MS (1) · Giles W. Robinson, MD (1)
PMID 34331515, PMID 37610803, PMID 37643378, PMID 37733309, PMID 41740060
2015 (1), 2023 (1)